Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

Dominantly Inherited Alzheimer Network (DIAN)

OBSERVATIONALInicio: 1 de ene de 2009ID: NCT00869817

ReclutandoClinicalTrials.gov

Physiological Umbilical Cord Clamping in Patients With Congenital Diaphragmatic Hernia. Clinical Trial

INTERVENTIONALInicio: 14 de jun de 2022ID: NCT06408376

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

INTERVENTIONALInicio: 24 de abr de 2025ID: NCT06875310

ReclutandoClinicalTrials.gov

Clinical Validation Cross-sectional Study for Colorectal Cancer Assessment Using Delta-HLD Technology (CLIMBED)

OBSERVATIONALInicio: 4 de abr de 2024ID: NCT07168876

ReclutandoClinicalTrials.gov

Memory for Music: Effects of Individual Intensive Musical Training Based on Singing in Non-musicians With Alzheimer's Disease

INTERVENTIONALInicio: 1 de dic de 2024ID: NCT06611878

ReclutandoFase 3ClinicalTrials.gov

A 6-month Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and PK/PD of an age-and Body Weight-adjusted Oral Finerenone Regimen, in Addition to an ACEI or ARB, for the Treatment of Children, 6 Months to <18 Years of Age, With Chronic Kidney Disease and Proteinuria

INTERVENTIONALInicio: 28 de mar de 2022ID: NCT05196035

ReclutandoClinicalTrials.gov

Medtronic Product Surveillance Registry

OBSERVATIONALInicio: 1 de ene de 2012ID: NCT01524276

ReclutandoClinicalTrials.gov

Post Authorization Study to Monitor Efficacy, Effectiveness, and Safety of Maribavir (LIVTENCITY®) in Patients With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

OBSERVATIONALInicio: 3 de sept de 2024ID: NCT06213974

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared With Investigator's Choice Monotherapy Treatment in Previously Treated Patients With Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma

INTERVENTIONALInicio: 25 de jun de 2024ID: NCT06496178

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)

INTERVENTIONALInicio: 13 de may de 2025ID: NCT06925737

ReclutandoFase 1ClinicalTrials.gov

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)

INTERVENTIONALInicio: 17 de sept de 2024ID: NCT06333951

ReclutandoFase 2ClinicalTrials.gov

A Prospective, Multi-Centre Study (B-Sure) to Evaluate Long-Term Durability of Treatment Response in Chronic Hepatitis B Participants With and Without Nucleos(t)Ide Therapy Who Have Participated in a Previous Bepirovirsen Treatment Study

INTERVENTIONALInicio: 14 de dic de 2021ID: NCT04954859

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Period and Long-term Extension to Assess the Efficacy and Safety of Rilzabrutinib in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

INTERVENTIONALInicio: 18 de ago de 2025ID: NCT07086976

ReclutandoFase 3ClinicalTrials.gov

18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

INTERVENTIONALInicio: 30 de jun de 2025ID: NCT07082725

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants With Chronic Kidney Disease and High Blood Pressure

INTERVENTIONALInicio: 3 de mar de 2025ID: NCT06742723

ReclutandoFase 1ClinicalTrials.gov

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subjects With Advanced Solid Tumors

INTERVENTIONALInicio: 2 de jul de 2024ID: NCT06431594

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

INTERVENTIONALInicio: 29 de may de 2025ID: NCT07035093

ReclutandoFase 3ClinicalTrials.gov

ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction

INTERVENTIONALInicio: 25 de jun de 2024ID: NCT06118281

ReclutandoFase 3ClinicalTrials.gov

A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER

INTERVENTIONALInicio: 10 de dic de 2025ID: NCT07282665

ReclutandoFase 2ClinicalTrials.gov

A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants With PMN (Primary Membranous Nephropathy) Who Are at a High Risk for Disease Progression

INTERVENTIONALInicio: 19 de sept de 2025ID: NCT07157787